Fer-1 treatment improved the impaired insulin sensitivity, disrupted estrous cycle, increased LH/FSH ratio, hyperandrogenism, and abnormal ovarian morphologies in PCOS rats. Here, BRD2 is linked to polycystic ovary syndrome.